A case report of remarkable response to association of radiofrequency ablation with subsequent Atezolizumab in stage IV nonsmall cell lung cancer

RATIONALE: Programmed cell death-1 (PD-1) or programmed death-ligand 1 (PD-L1) immune checkpoint inhibitors have demonstrated impressive efficacy in patients with nonsmall cell lung cancer (NSCLC). Radiofrequency ablation (RFA) is an alternative locoregional therapy for patients with inoperable NSCL...

Descripción completa

Detalles Bibliográficos
Autores principales: Yin, Jie, Dong, Jingyin, Gao, Wei, Wang, Yina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6221714/
https://www.ncbi.nlm.nih.gov/pubmed/30383701
http://dx.doi.org/10.1097/MD.0000000000013112

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6221714/
https://www.ncbi.nlm.nih.gov/pubmed/30383701
http://dx.doi.org/10.1097/MD.0000000000013112

Ejemplares similares